908 Devices (NASDAQ:MASS – Get Free Report) and WORK Medical Technology Group (NASDAQ:WOK – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation.
Profitability
This table compares 908 Devices and WORK Medical Technology Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 908 Devices | -62.40% | -14.03% | -10.40% |
| WORK Medical Technology Group | N/A | N/A | N/A |
Earnings and Valuation
This table compares 908 Devices and WORK Medical Technology Group”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| 908 Devices | $56.20 million | 4.47 | $19.49 million | ($1.00) | -6.64 |
| WORK Medical Technology Group | $9.85 million | 0.00 | -$1.07 million | N/A | N/A |
908 Devices has higher revenue and earnings than WORK Medical Technology Group.
Institutional and Insider Ownership
88.1% of 908 Devices shares are held by institutional investors. 28.2% of 908 Devices shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for 908 Devices and WORK Medical Technology Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 908 Devices | 1 | 0 | 1 | 0 | 2.00 |
| WORK Medical Technology Group | 1 | 0 | 0 | 0 | 1.00 |
908 Devices presently has a consensus price target of $12.00, suggesting a potential upside of 80.72%. Given 908 Devices’ stronger consensus rating and higher probable upside, equities analysts clearly believe 908 Devices is more favorable than WORK Medical Technology Group.
Risk & Volatility
908 Devices has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, WORK Medical Technology Group has a beta of 2.37, suggesting that its share price is 137% more volatile than the S&P 500.
Summary
908 Devices beats WORK Medical Technology Group on 8 of the 12 factors compared between the two stocks.
About 908 Devices
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
About WORK Medical Technology Group
WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.
